Skip to main content
Figure 1 | BMC Research Notes

Figure 1

From: Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy

Figure 1

Effect of 17-AAG on tumour volume of MMTV-NEU-NT tumours in transgenic mice: Mice were treated with 17-AAG (40mg/kg, days 1-3) with subsequent regrowth (■), vehicle treated controls (□). Tumour volume is expressed as % of volume at day 0. Data are presented as mean ± SEM (n = 4).

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us